Ryerson CAO granted dividend-equivalent RSUs

Ryerson’s CAO received additional RSU-based dividend equivalent rights linked to prior equity awards, vesting from 2027 through 2029.

Rhea-AI Filing Summary

Ryerson Holding Corp (symbol: RYZ) is the issuer of record for a Form 4 filing submitted to the SEC. Kannan Molly D reported acquisition or exercise transactions in this Form 4 filing.

Ryerson Holding Corp (RYZ) reported that officer Molly D. Kannan, CAO & Corporate Controller, received three grants of restricted stock units representing dividend equivalent rights on September 17, 2026. The awards cover 15.779, 34.806, and 50.482 units, each equal to one share of common stock, tied to prior RSU grants from 2024–2026 with scheduled vesting dates through March 31, 2029. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 101.067 shares

Grant/Award 3 txns

Insider Kannan Molly D

Role CAO & Corporate Controller

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2, F3	15.779	$0.00	$0.00
Grant/Award	Restricted Stock Units F1, F2, F4	34.806	$0.00	$0.00
Grant/Award	Restricted Stock Units F1, F2, F5	50.482	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 13,404.019 contracts (Direct)

Footnotes (5)

1. F1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").
2. F2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.
3. F3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027.
4. F4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027 and March 31, 2028.
5. F5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2026 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027, March 31, 2028, and March 31, 2029.

Key Figures

RSU dividend equivalent rights grant 1: 15.779 units RSU dividend equivalent rights grant 2: 34.806 units RSU dividend equivalent rights grant 3: 50.482 units +2 more

5 metrics

RSU dividend equivalent rights grant 1 15.779 units Restricted stock units granted September 17, 2026 tied to March 31, 2024 RSUs; vest March 31, 2027

RSU dividend equivalent rights grant 2 34.806 units Restricted stock units granted September 17, 2026 tied to March 31, 2025 RSUs; vest March 31, 2027 and March 31, 2028

RSU dividend equivalent rights grant 3 50.482 units Restricted stock units granted September 17, 2026 tied to March 31, 2026 RSUs; vest March 31, 2027, March 31, 2028, and March 31, 2029

RSU-to-share ratio 1 share per unit Each restricted stock unit represents a contingent right to receive one share of common stock

Transaction date September 17, 2026 Date of all three RSU dividend equivalent rights acquisitions

Key Terms

Restricted Stock Units, dividend equivalent rights, contingent right

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend equivalent rights financial

"Represents dividend equivalent rights that accrued on the underlying award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity awards were reported at Ryerson Holding Corp (RYZ)?

Ryerson reported that CAO & Corporate Controller Molly D. Kannan received three grants of restricted stock units representing dividend equivalent rights on September 17, 2026, tied to prior RSU awards granted in 2024, 2025, and 2026.

How many restricted stock units did the Ryerson (RYZ) officer receive in this Form 4?

The officer received restricted stock units representing dividend equivalent rights totaling 15.779, 34.806, and 50.482 units. Each unit represents a contingent right to receive one share of Ryerson Holding Corp common stock, subject to vesting conditions.

What are dividend equivalent rights in the Ryerson (RYZ) Form 4 filing?

Dividend equivalent rights are amounts that accrue on restricted stock units when and as dividends are paid on the underlying common shares. They vest proportionately with, and are settled or expire on the same terms as, the related restricted stock units.

When will the reported Ryerson (RYZ) RSU dividend equivalent rights vest?

The dividend equivalent rights tied to RSUs granted in 2024 vest on March 31, 2027; those tied to 2025 grants vest on March 31, 2027 and March 31, 2028; and those tied to 2026 grants vest on March 31, 2027, 2028, and 2029.

Was a Rule 10b5-1 trading plan involved in this Ryerson (RYZ) Form 4?

No. The filing indicates that no Rule 10b5-1 plan is reported for these transactions, which are grant or award acquisitions of restricted stock units representing dividend equivalent rights rather than market purchases or sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 04:43 PM Accepted by SEC EDGAR 09/21/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kannan Molly D

(Last) (First) (Middle)

C/O RYERSON HOLDING CORPORATION

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO & Corporate Controller

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/17/2026		A		15.779(2)		(3)	(3)	Common Stock	15.779	$0	2,092.702	D
Restricted Stock Units	(1)	09/17/2026		A		34.806(2)		(4)	(4)	Common Stock	34.806	$0	4,616.159	D
Restricted Stock Units	(1)	09/17/2026		A		50.482(2)		(5)	(5)	Common Stock	50.482	$0	6,695.158	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company").

2. Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate.

3. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027.

4. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2025 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027 and March 31, 2028.

5. The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2026 and outstanding as of September 17, 2026. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2027, March 31, 2028, and March 31, 2029.

	/s/ Camilla Rykke Merrick, attorney-in-fact	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)